In medical news:

The FDA announced yesterday that all immediate-release opioid painkillers will now feature a highlighted warning about the serious risks of misuse, abuse, addiction, overdose and death. According to the FDA’s statement on the matter, the new label says that opioids “should be reserved for pain severe enough to require opioid treatment and for which alternative treatment options (e.g., non-opioid analgesics or opioid combination products, as appropriate) are inadequate or not tolerated.” The FDA is also requiring several additional safety labeling changes across all prescription opioid products.

Read the announcement in full here and additional coverage from Business Insurance here.

Leave a Comment

Your email address will not be published. Required fields are marked *